Reaching beyond the review of research evidence: a qualitative study of decision making during the development of clinical practice guidelines for disease prevention in healthcare

被引:25
|
作者
Sundberg, Linda Richter [1 ,2 ]
Garvare, Rickard [3 ]
Nystrom, Monica Elisabeth [1 ,4 ]
机构
[1] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, SE-90187 Umea, Sweden
[2] Umea Univ, Dept Clin Sci Child & Adolescent Psychiat, SE-90187 Umea, Sweden
[3] Lulea Univ Technol, Dept Business Adm Technol & Social Sci, SE-97187 Lulea, Sweden
[4] Karolinska Inst, Med Management Ctr, Dept Learning Informat Management & Eth, SE-17177 Stockholm, Sweden
关键词
Clinical practice guidelines; Guideline development; Evidence-based policy-making; Group decision making; Prevention; IMPLEMENTATION; CONSENSUS; APPROPRIATENESS; RECOMMENDATIONS; SPECIALTY; FRAMEWORK; MEDICINE; DONT;
D O I
10.1186/s12913-017-2277-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The judgment and decision making process during guideline development is central for producing high-quality clinical practice guidelines, but the topic is relatively underexplored in the guideline research literature. We have studied the development process of national guidelines with a disease-prevention scope produced by the National board of Health and Welfare (NBHW) in Sweden. The NBHW formal guideline development model states that guideline recommendations should be based on five decision-criteria: research evidence; curative/preventive effect size, severity of the condition; cost-effectiveness; and ethical considerations. A group of health profession representatives (i.e. a prioritization group) was assigned the task of ranking condition-intervention pairs for guideline recommendations, taking into consideration the multiple decision criteria. The aim of this study was to investigate the decision making process during the two-year development of national guidelines for methods of preventing disease. Methods: A qualitative inductive longitudinal case study approach was used to investigate the decision making process. Questionnaires, non-participant observations of nine two-day group meetings, and documents provided data for the analysis. Conventional and summative qualitative content analysis was used to analyse data. Results: The guideline development model was modified ad-hoc as the group encountered three main types of dilemmas: high quality evidence vs. low adoptability of recommendation; insufficient evidence vs. high urgency to act; and incoherence in assessment and prioritization within and between four different lifestyle areas. The formal guideline development model guided the decision-criteria used, but three new or revised criteria were added by the group: 'clinical knowledge and experience', 'potential guideline consequences' and 'needs of vulnerable groups'. The frequency of the use of various criteria in discussions varied over time. Gender, professional status, and interpersonal skills were perceived to affect individuals' relative influence on group discussions. Conclusions: The study shows that guideline development groups make compromises between rigour and pragmatism. The formal guideline development model incorporated multiple aspects, but offered few details on how the different criteria should be handled. The guideline development model devoted little attention to the role of the decision-model and group-related factors. Guideline development models could benefit from clarifying the role of the group-related factors and non-research evidence, such as clinical experience and ethical considerations, in decision-processes during guideline development.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Practice guidelines in the context of primary care, learning and usability in the physicians’ decision-making process – a qualitative study
    Maria Ingemansson
    Pia Bastholm-Rahmner
    Anna Kiessling
    BMC Family Practice, 15
  • [32] Practice guidelines in the context of primary care, learning and usability in the physicians' decision-making process - a qualitative study
    Ingemansson, Maria
    Bastholm-Rahmner, Pia
    Kiessling, Anna
    BMC FAMILY PRACTICE, 2014, 15
  • [33] Adherence to European Clinical Practice Guidelines for Secondary Prevention of Cardiovascular Disease: A Cohort Study
    Pepio Vilaubi, Josep Maria
    Orozco-Beltran, Domingo
    Queiroga Goncalves, Alessandra
    Rodriguez Cumplido, Dolors
    Aguilar Martin, Carina
    Lopez-Pineda, Adriana
    Gil-Guillen, Vicente F.
    Quesada, Jose A.
    Carratala-Munuera, Concepcion
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (06)
  • [34] PREVENTION, DETECTION, AND MANAGEMENT OF EARLY CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW OF CLINICAL PRACTICE GUIDELINES
    Lopez-Vargas, P.
    Tong, A.
    Sureshkumar, P.
    Johnson, D.
    Craig, J.
    NEPHROLOGY, 2012, 17 : 51 - 52
  • [35] Prevention, detection and management of early chronic kidney disease: A systematic review of clinical practice guidelines
    Lopez-Vargas, Pamela A.
    Tong, Allison
    Sureshkumar, Premala
    Johnson, David W.
    Craig, Jonathan C.
    NEPHROLOGY, 2013, 18 (09) : 592 - 604
  • [36] Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease Shared Decision Making in Clinical Practice
    Mora, Samia
    Ames, Jeffrey M.
    Manson, JoAnn E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (07): : 709 - 710
  • [37] Physicians' Decision Making on Adoption of New Technologies and Role of Coverage with Evidence Development: A Qualitative Study
    Felgner, Susanne
    Ex, Patricia
    Henschke, Cornelia
    VALUE IN HEALTH, 2018, 21 (09) : 1069 - 1076
  • [38] Barriers and facilitators for the development of sex/gender sensitive clinical practice guidelines: A qualitative interview study
    Zeitler, Julia
    Babitsch, Birgit
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2018, 135 : 65 - 71
  • [39] Enhancing the evidence-based healthcare principles in clinical practice guidelines development in the Czech Republic: a best practice implementation project
    Vrbova, Tereza
    Klugarova, Jitka
    Pokorna, Andrea
    Dusek, Ladislav
    Licenik, Radim
    Klugar, Miloslav
    JBI EVIDENCE IMPLEMENTATION, 2022, 20 : S67 - S75
  • [40] How to integrate research evidence on patient preferences in pharmaceutical coverage decisions and clinical practice guidelines: A qualitative study among Dutch stakeholders
    Utens, Cecile M. A.
    Dirksen, Carmen D.
    van der Weijden, Trudy
    Joore, Manuela A.
    HEALTH POLICY, 2016, 120 (01) : 120 - 128